Eli Lilly | LLY - Capitalisation Boursière

Prix De L'Action
851.21
Variation Quotidienne
-22.79 -2.61%
Mensuellement
-3.99%
Annuel
-5.31%
Q2 Prévisions
865.04




Capitalisation Boursière Changement Date
AbbVie USD 360.74B 23.94B 2026-04
Abbott USD 168.02B 10.39B 2026-04
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 214.75B 86.5B 2026-04
Baxter International USD 9.82B 1.87B 2025-12
Biogen USD 28.34B 1.44B 2026-04
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 79.5B 4.3B 2026-04
Glaxosmithkline GBP 99.93B 13.05B 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Regeneron Pharmaceuticals USD 73.97B 7.71B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Zoetis USD 55.45B 9.4B 2025-12